Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.
Fingolimod Increases CD39-Expressing Regulatory T Cells in Multiple Sclerosis Patients.
Self-tolerance in multiple sclerosis.
Editorial: new avenues of research on multiple sclerosis from the perspective of chronic cerebrospinal venous insufficiency paradigm.
Reproductive decision making after the diagnosis of multiple sclerosis (MS).
Association of a deficit of arousal with fatigue in multiple sclerosis: Effect of modafinil.
Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination.
Enhancement of Membrane B7-H3 Costimulatory Molecule but Reduction of Its Soluble Form in Multiple Sclerosis.
Control of TH17 cells occurs in the small intestine.
Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE.
Lower urinary tract symptoms of neurological origin in urological practice.
Home-Based Balance Training Using the Wii Balance Board: A Randomized, Crossover Pilot Study in Multiple Sclerosis.
Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation.
The relation between peptide hormones and sex hormone in patients with multiple sclerosis.
Evaluation of changes in retinal nerve fiber layer thickness and visual functions in cases of optic neuritis and multiple sclerosis.
Signaling and Regulatory Functions of Bioactive Sphingolipids as Therapeutic Targets in Multiple Sclerosis.
Recommendations for the detection and therapeutic management of cognitive impairment in multiple sclerosis.
Seasonality of multiple sclerosis and neuromyelitis optica exacerbations in Japan.
Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.
Tumor necrosis factor beta (TNF-β) NcoI polymorphism is associated with multiple sclerosis in Caucasian patients from Southern Brazil independently from HLA-DRB1.
No association of IFI16 (interferon-inducible protein 16) variants with susceptibility to multiple sclerosis.
Integrated clinical and specialty pharmacy practice model for management of patients with multiple sclerosis.
[Sphingosine-1-phosphate signaling system and the innovative mechanism of action of fingolimod in treatment of multiple sclerosis: review of foreign literature.]
Immune responses in rapidly progressive dementia: a comparative study of neuroinflammatory markers in Creutzfeldt-Jakob disease, Alzheimer¿s disease and multiple sclerosis.
Tumefactive demyelination: an approach to diagnosis and management.

Pages